These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33580106)

  • 1. Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis.
    Irvine AF; Waise S; Green EW; Stuart B; Thomas GJ
    Sci Rep; 2021 Feb; 11(1):3727. PubMed ID: 33580106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
    Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
    Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Distinct Populations of Carcinoma-Associated Fibroblasts from Non-Small Cell Lung Carcinoma Reveals a Role for ST8SIA2 in Cancer Cell Invasion.
    Hao J; Zeltz C; Pintilie M; Li Q; Sakashita S; Wang T; Cabanero M; Martins-Filho SN; Wang DY; Pasko E; Venkat K; Joseph J; Raghavan V; Zhu CQ; Wang YH; Moghal N; Tsao MS; Navab R
    Neoplasia; 2019 May; 21(5):482-493. PubMed ID: 30978569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome.
    Mathieson L; Koppensteiner L; Dorward DA; O'Connor RA; Akram AR
    Br J Cancer; 2024 May; 130(11):1758-1769. PubMed ID: 38582812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
    Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
    J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers.
    Kilvaer TK; Khanehkenari MR; Hellevik T; Al-Saad S; Paulsen EE; Bremnes RM; Busund LT; Donnem T; Martinez IZ
    PLoS One; 2015; 10(8):e0134965. PubMed ID: 26252379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD66b
    Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
    Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
    Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
    J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients.
    Li K; Wang R; Liu GW; Peng ZY; Wang JC; Xiao GD; Tang SC; Du N; Zhang J; Zhang J; Ren H; Sun X; Yang YP; Liu DP
    Sci Rep; 2024 Jul; 14(1):16766. PubMed ID: 39034310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer.
    Zhang Y; Bian Y; Wang Y; Wang Y; Duan X; Han Y; Zhang L; Wang F; Gu Z; Qin Z
    J Cell Mol Med; 2021 Jun; 25(12):5457-5469. PubMed ID: 33943003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of combining immunohistochemical markers for cancer-associated fibroblasts in lung adenocarcinoma tissue.
    Inoue C; Tamatsuki D; Miki Y; Saito R; Okada Y; Sasano H
    Virchows Arch; 2019 Aug; 475(2):181-189. PubMed ID: 31134329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
    Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
    PeerJ; 2024; 12():e16958. PubMed ID: 38410801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms.
    Hu H; Piotrowska Z; Hare PJ; Chen H; Mulvey HE; Mayfield A; Noeen S; Kattermann K; Greenberg M; Williams A; Riley AK; Wilson JJ; Mao YQ; Huang RP; Banwait MK; Ho J; Crowther GS; Hariri LP; Heist RS; Kodack DP; Pinello L; Shaw AT; Mino-Kenudson M; Hata AN; Sequist LV; Benes CH; Niederst MJ; Engelman JA
    Cancer Cell; 2021 Nov; 39(11):1531-1547.e10. PubMed ID: 34624218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer.
    Cords L; Engler S; Haberecker M; Rüschoff JH; Moch H; de Souza N; Bodenmiller B
    Cancer Cell; 2024 Mar; 42(3):396-412.e5. PubMed ID: 38242124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
    Yanagawa N; Sugai M; Shikanai S; Sugimoto R; Osakabe M; Uesugi N; Saito H; Maemondo M; Sugai T
    Thorac Cancer; 2022 Aug; 13(16):2377-2384. PubMed ID: 35818720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling.
    Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Alfaro C; Sanchez JC; Franco F; Calvo V; Romero A; Martin-Acosta P; Salas C; Garcia JM; Provencio M
    Free Radic Biol Med; 2019 Jan; 130():163-173. PubMed ID: 30391585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.